Tongxinluo ameliorates renal structure and function by regulating miR-21-induced epithelial-to-mesenchymal transition in diabetic nephropathy.
about
Tongxinluo Protects against Hypertensive Kidney Injury in Spontaneously-Hypertensive Rats by Inhibiting Oxidative Stress and Activating Forkhead Box O1 Signaling.Effect of Tongxinluo on Nephrin Expression via Inhibition of Notch1/Snail Pathway in Diabetic RatsPGC-1α Mediated Peripheral Nerve Protection of Tongxinluo in STZ-Induced Diabetic Rats.C66 ameliorates diabetic nephropathy in mice by both upregulating NRF2 function via increase in miR-200a and inhibiting miR-21Review of Herbal Traditional Chinese Medicine for the Treatment of Diabetic Nephropathy.Epigenetics of kidney disease.Ursolic acid improves podocyte injury caused by high glucose.Inhibition of miR-128-3p by Tongxinluo Protects Human Cardiomyocytes from Ischemia/reperfusion Injury via Upregulation of p70s6k1/p-p70s6k1.Metformin ameliorates skeletal muscle insulin resistance by inhibiting miR-21 expression in a high-fat dietary rat model.Tongxinluo Inhibits Renal Fibrosis in Diabetic Nephropathy: Involvement of the Suppression of Intercellular Transfer of TGF-[Formula: see text]1-Containing Exosomes from GECs to GMCs.Chrysin inhibits diabetic renal tubulointerstitial fibrosis through blocking epithelial to mesenchymal transition.Tongxinluo attenuates reperfusion injury in diabetic hearts by angiopoietin-like 4-mediated protection of endothelial barrier integrity via PPAR-α pathway.Astragaloside IV improves renal function and fibrosis via inhibition of miR-21-induced podocyte dedifferentiation and mesangial cell activation in diabetic miceTriptolide Attenuates Renal Tubular Epithelial-mesenchymal Transition Via the MiR-188-5p-mediated PI3K/AKT Pathway in Diabetic Kidney Disease
P2860
Q35870169-D5E94F4F-53A1-42A2-9299-7DF0C261A982Q36055970-9C0BCB10-0776-4F29-800F-C2A28F95DD51Q37140731-B4DCA59D-466A-4027-9722-E4FE9685D60EQ37603152-7BB5C60D-185F-427F-A904-C7033B11B33CQ38663562-F33DFDB7-852D-457B-92FE-9FE0CBAFFC6AQ39175636-9B06E2F1-DE06-46E6-8701-06C7E1D06AD8Q40322512-3E759371-B24E-4D15-B60E-E3AC63480BD1Q44409387-FE6FE795-737D-4B60-A540-52185D53803BQ47118967-6051EC04-CA43-44F5-8595-8B7F9E37FC92Q50918327-2AACD2A8-0918-4A8E-9718-C07250CD4AEFQ52660876-66119EC9-E734-4BC1-898D-70A909A47C9BQ55285122-CCD81E9A-D820-4E32-9C94-1EC713CEB2DAQ57170561-6D7CBDD2-E817-4A5E-8DF0-C54DAE60585DQ58758555-016A22B6-F099-4B1E-A90D-02B2F65CE257
P2860
Tongxinluo ameliorates renal structure and function by regulating miR-21-induced epithelial-to-mesenchymal transition in diabetic nephropathy.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Tongxinluo ameliorates renal s ...... ition in diabetic nephropathy.
@ast
Tongxinluo ameliorates renal s ...... ition in diabetic nephropathy.
@en
type
label
Tongxinluo ameliorates renal s ...... ition in diabetic nephropathy.
@ast
Tongxinluo ameliorates renal s ...... ition in diabetic nephropathy.
@en
prefLabel
Tongxinluo ameliorates renal s ...... ition in diabetic nephropathy.
@ast
Tongxinluo ameliorates renal s ...... ition in diabetic nephropathy.
@en
P2093
P2860
P1476
Tongxinluo ameliorates renal s ...... ition in diabetic nephropathy.
@en
P2093
Da-wei Zou
Fang-qiang Cui
Jian-guo Geng
Jiao-yang Li
Jin-kui Yang
Jin-yang Wang
Li-ping Xu
Sheng-nan Zhou
Xiang-jun Zeng
P2860
P304
P356
10.1152/AJPRENAL.00528.2013
P577
2013-12-26T00:00:00Z